Condition (MeSH)
Furcation Defects
ClinicalTrials.gov lists 38 trials for Furcation Defects or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase (log scale)
38 of the 38 trials are tagged with Furcation Defects itself; the rest are tagged with a narrower condition beneath it.
When did Furcation Defects trials start? (16)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1
- Phase 2/3
- Phase 4
- Not applicable
- Observational
Top of scale: 5
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 1 |
| 2024 | 3 |
| 2023 | 5 |
| 2022 | 5 |
| 2021 | 2 |
| 2020 | 1 |
| 2019 | 4 |
| 2018 | 2 |
| 2017 | 2 |
Showing 10 of 16 earlier years.
No forecast is made for this condition: it averages 3.6 trial starts a year over the five years to September, under the 5 a year the method needs.
Prediction, not a registry value: median of 36 months from start to primary completion across 9 trials still running at the 2026-10-09 snapshot; registered median of 15 months across 19 trials with a primary completion typed Actual. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Furcation Defects trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1 | 1 |
| Phase 2/3 | 3 |
| Phase 4 | 4 |
| Not applicable | 28 |
| Observational | 2 |
How many Furcation Defects trials are recruiting? (7)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Not yet recruiting | 1 |
| Recruiting | 4 |
| Active, not recruiting | 2 |
| Completed | 16 |
| Terminated | 2 |
Showing 5 of 7 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Furcation Defects? (3)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Platelet Rich Fibrin | 3 |
| ROSUVASTATIN | 1 |
| Leukocyte Platelet Rich Fibrin | 1 |
Interventions as named in the registry (9)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| open flap debridement | 5 |
| Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain) | 2 |
| Emdogain | 1 |
| Enamel Matrix Derivative (Emdogain) | 1 |
| Group I | 1 |
Showing 5 of 9 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Furcation Defects? (69)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Complications and treatment errors related to regenerative periodontal surgery. | Periodontology 2000 | 2023 | Yes |
| Resective surgery for the treatment of furcation involvement: A systematic review. | Journal of clinical periodontology | 2020 | Yes |
| Vital root resection in severely furcation-involved maxillary molars: Outcomes after up to 7 years. | Journal of clinical periodontology | 2020 | Yes |
| Mandibular Degree II Furcation Defects Treatment With Platelet-Rich Fibrin and 1% Alendronate Gel Combination: A Randomized Controlled Clinical Trial. | Journal of periodontology | 2017 | Yes |
| 1.2% Rosuvastatin and 1.2% Atorvastatin Gel Local Drug Delivery and Redelivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial. | Journal of periodontology | 2017 | Yes |
Showing 5 of 69 publications.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, rare-disease identity, and sub-conditions in mesh.